Doxefazepam

Doxefazepam
Doxefazepam
Systematic (IUPAC) name
9-chloro-6-(2-fluorophenyl)-4-hydroxy
-2-(2-hydroxyethyl)-2,5-diazabicyclo
[5.4.0]undeca-5,8,10,12-tetraen-3-one
Clinical data
Pregnancy cat.  ?
Legal status Schedule IV(US)
Routes Oral
Pharmacokinetic data
Bioavailability  ?
Metabolism Hepatic
Half-life 3-4 hours[1]
Excretion Renal
Identifiers
CAS number 40762-15-0 N
ATC code N05CD12
PubChem CID 38668
DrugBank ?
ChemSpider 35431 YesY
UNII verifiedrevid = 457288969 231RV72C8L verifiedrevid = 457288969 N
KEGG D07327 YesY
ChEMBL CHEMBL64677 YesY
Chemical data
Formula C17H14ClFN2O3 
Mol. mass 348.8
SMILES eMolecules & PubChem
 N(what is this?)

Doxefazepam (marketed under brand name Doxans) is a benzodiazepine derivative drug developed by Schiapparelli in the 1970s[2]. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It is used therapeutically as a hypnotic.[3] According to Babbini and colleagues in 1975, this derivative of flurazepam was between 2 and 4 times more potent than the latter while at the same time being half as toxic in laboratory animals.[4]

See also

References

  1. ^ http://www.intox.org/databank/documents/pharm/doxefzpm/iarc796.htm
  2. ^ DE Patent 2338058 - BENZODIAZEPINVERBINDUNGEN FUER DIE THERAPIE
  3. ^ Rodriguez, G; Rosadini, G; Sannita, WG; Strumia, E (1984). "Effects of doxefazepam on normal sleep. An EEG and neuropsychological study". Neuropsychobiology 11 (2): 133–9. PMID 6483162. 
  4. ^ Babbini, M.; Torrielli MV, Strumia E, Gaiardi M, Bartoletti M, De Marchi F. (August 1975). "Sedative-hypnotic properties of a new benzodiazepine in comparison with flurazepam. Pharmacological and clinical findings". Arzneimittel-Forschung 25 (8): 1294–1300. PMID 241364. 

External links